Combination of insulin lispro (LP), metformin (MF), or bedtime NPH (NPH) with sulfonylurea (SU) following secondary SU failure

被引：0
作者：
Browdos, R
Schwartz, S
Stuart, CA
Zagar, A
Graf, CJ
Bastyr, EJ
机构：
来源：
DIABETES | 1999年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0450
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 33 条
[21]   COMBINATION OF INSULIN AND SULFONYLUREA (SU) IN THE TREATMENT OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES WITH SECONDARY FAILURE OF SU THERAPY (SF) - LONG-TERM RESULTS [J].
LOTZ, N ;
LADIK, T ;
RUPP, P ;
BACHMANN, W ;
MEHNERT, H .
DIABETOLOGIA, 1987, 30 (07) :A551-A551
[22]   COST EFFECTIVENESS EVALUATION OF CANAGLIFLOZIN IN COMBINATION WITH METFORMIN AND SULFONYLUREA IN COMPARISON TO NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN POLAND [J].
Szmurlo, D. ;
Drzal, R. ;
Plisko, R. ;
Schubert, A. ;
Skrzekowska-Baran, I .
VALUE IN HEALTH, 2014, 17 (07) :A351-A351
[23]   Sulfonylurea (SU) and bedtime NPH insulin vs. Humalog® Mix50™ before breakfast and Humalog® Mix25™ before dinner in patients failing combined oral treatment [J].
Milicevic, Z ;
Herz, M ;
Ivanyi, T ;
Metcalfe, S ;
Hancu, N ;
Car, N ;
Jermendy, G ;
Mittermayer, B .
DIABETES, 2002, 51 :A475-A475
[24]   Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus [J].
López-Alvarenga, JC ;
Aguilar-Salinas, CA ;
Velasco-Perez, ML ;
Arita-Melzer, O ;
Guillen, LE ;
Wong, B ;
Brito, G ;
Mercado, V ;
Gómez-Pérez, FJ ;
Rull-Rodrigo, JA .
DIABETES OBESITY & METABOLISM, 1999, 1 (01) :29-35
[25]   Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: A 1-year follow-up [J].
Clauson, P ;
Karlander, S ;
Steen, L ;
Efendic, S .
DIABETIC MEDICINE, 1996, 13 (05) :471-477
[26]   Therapy change and progression to insulin use amongtype-2 diabetic patients newly treated with sulfonylurea (SU) or metformin (MF) monotherapy [J].
Kerasidou, O ;
Yin, D ;
Lyu, R .
VALUE IN HEALTH, 2004, 7 (06) :744-744
[27]   TREATMENT OF NIDDM PATIENTS WITH SECONDARY FAILURE TO GLYBURIDE - COMPARISON OF THE ADDITION OF EITHER METFORMIN OR BED-TIME NPH INSULIN TO GLYBURIDE [J].
VIGNERI, R ;
TRISCHITTA, V ;
ITALIA, S ;
MAZZARINO, S ;
RABUAZZO, MA ;
SQUATRITO, S .
DIABETES & METABOLISM, 1991, 17 (1BIS) :232-234
[28]   Experience of hypoglycemia is significantly associated with lower quality of life (euroqol) in diabetic patients on metformin (mf) plus Pparγ agonist or Mf plus sulfonylurea (su) combination therapies [J].
Mavros, Panagiotis ;
Krishnarajah, Girishanthy ;
Lyu, Ramon ;
Yin, Donald .
DIABETES, 2007, 56 :A584-A584
[29]   Insulin Lispro (LP) versus Humulin 70/30 following secondary oral agent failure in primary care [J].
Bastyr, EJ ;
Zagar, A ;
Graf, CJ ;
Fletcher, AL .
DIABETES, 2000, 49 :A97-A97
[30]   Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure [J].
Kokic, S ;
Bukovic, D ;
Radman, M ;
Capkun, V ;
Gabric, N ;
Lesko, V ;
Karelovic, D ;
Stanceric, T .
COLLEGIUM ANTROPOLOGICUM, 2003, 27 (01) :181-187
1234